InsidersTradesSigma
Track the Polaryx Therapeutics, Inc. share price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). The latest transaction was filed on 20 February 2026 (Acquisition). Among the most active insiders: Landis G. Michael. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Polaryx Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative treatments for rare diseases. It is listed on NASDAQ under the ticker PLYX.